Empagliflozin improves endothelial and cardiomyocyte function in human heart failure with preserved ejection fraction via reduced pro-inflammatory-oxidative pathways and protein kinase Gα oxidation
Detmar Kolijn, Steffen Pabel, Yanna Tian, Mária Lódi, Melissa Herwig, Albino Carrizzo, Saltanat Zhazykbayeva, Árpád Kovács, Gábor Fülöp, Inês Falcão-Pires, Peter H. Reusch, Sophie Van Linthout, Zoltán Papp, Loek Van Heerebeek, Carmine Vecchione, Lars S. Maier, Michele Ciccarelli, Carsten Tschöpe, Andreas Mügge, Zsolt BagiSamuel Sossalla, Nazha Hamdani
Dive into the research topics of 'Empagliflozin improves endothelial and cardiomyocyte function in human heart failure with preserved ejection fraction via reduced pro-inflammatory-oxidative pathways and protein kinase Gα oxidation'. Together they form a unique fingerprint.